Annual Cash & Cash Equivalents
$63.73 M
-$55.26 M-46.44%
31 March 2022
Summary:
Sio Gene Therapies annual cash & cash equivalents is currently $63.73 million, with the most recent change of -$55.26 million (-46.44%) on 31 March 2022. During the last 3 years, it has fallen by -$55.26 million (-46.44%).SIOX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$46.13 M
-$3.74 M-7.50%
31 December 2022
Summary:
Sio Gene Therapies quarterly cash and cash equivalents is currently $46.13 million, with the most recent change of -$3.74 million (-7.50%) on 31 December 2022.SIOX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -46.4% | -43.7% |
| 5 y5 years | -40.4% | +65.8% |
SIOX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -76.9% | -86.1% |
Sio Gene Therapies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $46.13 M(-7.5%) |
| Sept 2022 | - | $49.87 M(-9.0%) |
| June 2022 | - | $54.77 M(-14.1%) |
| Mar 2022 | $63.73 M(-46.4%) | $63.73 M(-22.2%) |
| Dec 2021 | - | $81.91 M(-19.5%) |
| Sept 2021 | - | $101.69 M(-8.4%) |
| June 2021 | - | $110.98 M(-6.7%) |
| Mar 2021 | $118.99 M(+47.3%) | $118.99 M(+46.9%) |
| Dec 2020 | - | $81.02 M(+28.3%) |
| Sept 2020 | - | $63.17 M(+13.9%) |
| June 2020 | - | $55.48 M(-31.3%) |
| Mar 2020 | $80.75 M(-24.5%) | $80.75 M(+190.3%) |
| Dec 2019 | - | $27.81 M(-53.8%) |
| Sept 2019 | - | $60.26 M(-28.4%) |
| June 2019 | - | $84.18 M(-21.3%) |
| Mar 2019 | $107.00 M | $107.00 M(+26.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | - | $84.94 M(-6.4%) |
| Sept 2018 | - | $90.73 M(-2.4%) |
| June 2018 | - | $92.93 M(-39.8%) |
| Mar 2018 | $154.34 M(-27.4%) | $154.34 M(-18.0%) |
| Dec 2017 | - | $188.25 M(-20.0%) |
| Sept 2017 | - | $235.37 M(-21.0%) |
| June 2017 | - | $297.86 M(+40.1%) |
| Mar 2017 | $212.57 M(-23.1%) | $212.57 M(+6.1%) |
| Dec 2016 | - | $200.41 M(-12.7%) |
| Sept 2016 | - | $229.66 M(-9.1%) |
| June 2016 | - | $252.66 M(-8.5%) |
| Mar 2016 | $276.25 M(>+9900.0%) | $276.25 M(-7.9%) |
| Dec 2015 | - | $300.00 M(-6.3%) |
| Sept 2015 | - | $320.21 M(-3.3%) |
| June 2015 | - | $331.07 M |
| Mar 2015 | $0.00 | - |
FAQ
- What is Sio Gene Therapies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sio Gene Therapies?
What is Sio Gene Therapies annual cash & cash equivalents?
The current annual cash & cash equivalents of SIOX is $63.73 M
What is the all time high annual cash & cash equivalents for Sio Gene Therapies?
Sio Gene Therapies all-time high annual cash & cash equivalents is $276.25 M
What is Sio Gene Therapies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SIOX is $46.13 M
What is the all time high quarterly cash and cash equivalents for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly cash and cash equivalents is $331.07 M